Emergent Biosolutions

EBS

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, opioid overdoses, and provides medical devices for biodefense purposes. The company's gross rev …

Insider trades and stock quote 2024-2026

All insider trades at Emergent Biosolutions

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/1/2026 Sell Williams, Paul Anthony SVP, Products Business $8.4 $25,200
5/1/2026 Sell Dayal, Sujata Tyagi Director $8.6 $115,610
5/1/2026 Sell Degolyer, Donald W. Director $8.7 $129,994
5/1/2026 Sell Zoon, Kathryn C. Director $8.7 $144,453
4/30/2026 Sell Katkin, Keith Director $8.3 $128,183
4/1/2026 Sell Williams, Paul Anthony SVP, Products Business $8.4 $33,760
12/5/2025 Sell Richard, Ronald Director $12.0 $263,077
11/10/2025 Sell Degolyer, Donald W. Director $10.5 $187,623
11/7/2025 Sell Dayal, Sujata Tyagi Director $10.0 $85,520
10/7/2025 Sell Glessner, Coleen EVP, Quality & Ethics, and CPL $10.0 $306,080
8/15/2025 Sell Zoon, Kathryn C. Director $8.9 $62,853
8/12/2025 Sell Degolyer, Donald W. Director $8.6 $67,831
5/23/2025 Sell Katkin, Keith Director $6.3 $49,417
5/13/2025 Buy Papa, Joseph C. President and CEO $5.8 $349,800
3/12/2025 Sell Zoon, Kathryn C. Director $5.7 $57,300
3/12/2025 Sell Fowler, Neal Franklin Director $5.8 $204,050
11/12/2024 Sell Degolyer, Donald W. Director $10.9 $272,750
11/11/2024 Sell White, Marvin L. Director $12.0 $171,015
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)